Individual therapy- and/or illness-related symptoms in post gynecological treatment
Conditions
Interventions
Group 1: The participants (n = 20) will receive five aromatherapeutic products from the Primavera® company to use over four weeks according to their own needs and circumstances. For orientation, they
Sponsors
Charité - Universitätsmedizin Berlin, Klinik für Pädiatrie m. S. Onkologie/Hämatologie, AG Integrative Medizin in der pädiatrischen Onkologie
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patient is undergoing follow-up care as a result of gynecological oncological disease/ breast cancer; at least 6 weeks have passed since the last intensive polychemotherapy; German language skills; written consent obtained for partici-pation and for the disclosure of pseudonymized data as part of the research documentation is available.
Exclusion criteria
Exclusion criteria: Allergies to the product or product-ingredients used; other existing diseases, skin changes, or health conditions that could interfere with treatment of participants according to the study protocol; participation in other studies that could interfere with study participation in the arth4WOMEN project.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In the qualitative part of the study, the participants will be interviewed after the intervention with regard to their perceptions of and experiences with the intervention. The interviews will be semi-structured and include narrative and association-based components. | — |
Secondary
| Measure | Time frame |
|---|---|
| Overview of participants’ personal illness- and/or treatment-related symptomatic burdens and the associated subjective stress level before and after the intervention. Collection of data will take place as follows: (1) At the beginning and end of the intervention: MYMOP assessment of individual participant symptoms and general well-being (2) During the intervention: Collection of quantitative and qualitative data on products, used, time and mode of application by an applica-tion protocol (= documentation poster) completed by participants. | — |
Countries
Germany
Contacts
Public ContactJudith Czakert
Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Klinik für Pädiatrie m. S. Onkologie/Hämatologie, AG Integrative Medizin
Outcome results
None listed